Tally Largent-Milnes, PhD, who once aspired to be a physician, has carved out an impactful space in the field of migraine research.

Academic researchers and industry professionals will discuss drug development at the Fifth Annual Arizona Drug Discovery and Development Summit.

Experts including Steven Dudley, PharmD, director of the Arizona Poison and Drug Information Center, discuss the health benefits of CBD products, as well as the possibility they could trigger false positive drug tests.

The Arizona Poison and Drug Information Center at the R. Ken Coit College of Pharmacy partnered with the Arizona Department of Health Services and Blackbox Healthcare Solutions to launch the Arizona Resource Equity and Access Coordination Hub, a program aimed at enhancing equitable access to care for rural communities.

The new molecules exploit the iron dependency of malignant cells and could lead to the development of new anticancer drugs.

Researchers at the UArizona Cancer Center discovered a new class of iron-targeting compounds that hamper the proliferation of cultured malignant cells in a laboratory setting. The results of the study were published in the Journal of the American Chemical Society.

Experts identify the germiest places at the airport. Kelly Reynolds, PhD, MSPH, professor and chair of the Department of Community, Environment and Policy in the Mel and Enid Zuckerman College of Public Health, is quoted.

College of Medicine – Phoenix student Kennedy Sparling, who aspires to be a pediatric dermatologist, writes about how her experiences with atopic dermatitis and keratosis pilaris inspired her career choice.

Deepta Bhattacharya, PhD, professor of immunobiology at the College of Medicine – Tucson, is interviewed about updated versions of the Moderna and Pfizer-BioNTech vaccines, formulated to help people fight off the new omicron subvariant of COVID-19.